drugset / Trial / NCT06164392

Evaluation of Neuroma Perfusion with Indocyanine Green Fluorescence Angiography

NCT06164392

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to characterize the perfusion of neuromas using indocyanine green fluorescence angiography

Timeline

Start
2024-12-28
Primary completion
2024-12-28
Completion
2024-12-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Indocyanine Green Diagnostic / imaging agent Intravenous

Indications